Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,038
Closed -$413K 34
2025
Q2
$413K Buy
3,038
+89
+3% +$11.7K 0.28% 67
2025
Q1
$391K Sell
2,949
-2,562
-46% -$326K 0.25% 58
2024
Q4
$623K Buy
5,511
+165
+3% +$19.1K 0.26% 61
2024
Q3
$609K Buy
5,346
+1,010
+23% +$111K 0.24% 63
2024
Q2
$451K Sell
4,336
-1,507
-26% -$160K 0.16% 85
2024
Q1
$664K Buy
+5,843
New +$670K 0.17% 86
2023
Q3
Sell
-2,215
Closed -$241K 141
2023
Q2
$241K Sell
2,215
-225
-9% -$24K 0.12% 155
2023
Q1
$247K Sell
2,440
-206
-8% -$21.8K 0.1% 154
2022
Q4
$291K Sell
2,646
-1,302
-33% -$135K 0.12% 132
2022
Q3
$382K Buy
3,948
+815
+26% +$86.9K 0.18% 84
2022
Q2
$340K Sell
3,133
-748
-19% -$84.9K 0.15% 99
2022
Q1
$459K Buy
3,881
+907
+30% +$112K 0.19% 87
2021
Q4
$419K Buy
+2,974
New +$381K 0.21% 98

Other funds holding ABT

ASB Consultores's ABT Position: Q3 2025 in Review

ASB Consultores sold out of Abbott (ABT) in Q3 2025, closing a stake of 3,038 shares — an estimated $413K sold.

ASB Consultores first reported a position in ABT in Q4 2021 and held it in 13 quarters. The position peaked at $664K in Q1 2024. 3,181 funds tracked by Wall St. Rank hold ABT as of Q3 2025.

  • ASB Consultores reported no remaining Abbott position as of Q3 2025 after selling out during the quarter.
  • ASB Consultores sold 3,038 Abbott shares in Q3 2025, an estimated $413K.
  • ASB Consultores first reported a position in Abbott in Q4 2021 and held it in 13 quarters.
  • ASB Consultores's Abbott position peaked at $664K in Q1 2024.
  • 3,181 funds tracked by Wall St. Rank held Abbott as of Q3 2025.

Based on ASB Consultores's 13F filing for Q3 2025, filed 4 Nov 2025.